Ending tuberculosis in Europe - resetting the course in the post-COVID-19 era
(Source: Eurosurveillance)
Source: Eurosurveillance - March 23, 2023 Category: Infectious Diseases Authors: Andrea Ammon and Hans Kluge Source Type: research
Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022
Persons fleeing Ukraine since February 2022 have potentially higher risk of tuberculosis (TB) vs all European Union countries. Interest of active TB screening among this population is debated and not widely adopted. In this screening intervention by a network of TB centres in France, the number needed to screen (NNS) was 862 to find one case. This experience shows that this strategy may be relevant for TB control in situations of massive displacement, similar to that following the Russian invasion. (Source: Eurosurveillance)
Source: Eurosurveillance - March 23, 2023 Category: Infectious Diseases Authors: Jean-Paul Guthmann, Philippe Fraisse, Isabelle Bonnet and J érôme Robert Source Type: research
Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
We report progress in the European Union/European Economic Area (EU/EEA) towards the Sustainable Development Goal target for tuberculosis (TB) and for the associated global/regional targets. The TB notification rate and the number of TB deaths declined since 2015 but, if current trends continue, the EU/EEA will not reach the 2030 targets. Performance on treatment initiation targets declined sharply during 2020–2021, while the percentage of TB cases with successful treatment outcomes remains low, at 47.9% of the multidrug-resistant TB cases. (Source: Eurosurveillance)
Source: Eurosurveillance - March 23, 2023 Category: Infectious Diseases Authors: Veronica Cristea, Csaba K ödmön, Senia Rosales-Klintz, Anastasia Pharris and Marieke J van der Werf Source Type: research
A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022
DiscussionZoonotic circulation ofM. caprae strains had gone unnoticed for 18 years. Systematic characterisation of MTBC at species level and/or extended investigation of the possible sources of exposure in all tuberculosis cases would minimise the risk of overlooking similar zoonotic events. (Source: Eurosurveillance)
Source: Eurosurveillance - March 23, 2023 Category: Infectious Diseases Authors: Miguel Mart ínez-Lirola, Marta Herranz, Sergio Buenestado Serrano, Cristina Rodríguez-Grande, Eva Dominguez Inarra, Jose Antonio Garrido-Cárdenas, Ana María Correa Ruiz, María Pilar Bermúdez, Manuel Causse del Río, Verónica González Galán, Julia Source Type: research
Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine
We describe characteristics of the first 1,000 mpox cases in the Netherlands, reported between 20 May and 8 August 2022, within the context of the public health response. These cases were predominantly men who have sex with men aged 31–45 years. The vast majority of infections were acquired through sexual contact with casual partners in private or recreational settings including LGBTQIA+ venues in the Netherlands. This indicates that, although some larger upsurges occurred from point-source and/or travel-related events, the outbreak was mainly characterised by sustained transmission within the Netherlands. In a...
Source: Eurosurveillance - March 23, 2023 Category: Infectious Diseases Authors: Catharina E van Ewijk, Fuminari Miura, Gini van Rijckevorsel, Henry JC de Vries, Matthijs RA Welkers, Oda E van den Berg, Ingrid HM Friesema, Patrick R van den Berg, Thomas Dalhuisen, Jacco Wallinga, Diederik Brandwagt, Brigitte AGL van Cleef, Harry Venne Source Type: research
A new method for near real-time, nationwide surveillance of nosocomial COVID-19 in Norway: providing data at all levels of the healthcare system, March 2020 to March 2022
ConclusionAutomated national surveillance for nosocomial COVID-19 is possible based on existing data sources. Beredt C19 provided detailed information with only 5% missing data on hospitals/wards. Epidemiological definitions are possible to standardise, enabling easier comparison between regions and countries. (Source: Eurosurveillance)
Source: Eurosurveillance - March 23, 2023 Category: Infectious Diseases Authors: H åvard Skagseth, Silje Bakken Jørgensen, Jacqui Reilly and Oliver Kacelnik Source Type: research
Tick-borne encephalitis virus IgG antibody surveillance: vaccination- and infection-induced seroprevalences, south-western Germany, 2021
ConclusionUsing the TBEV NS1 IgG assay, we confirmed a manifestation index of ca 2% and a high incidence of predominantly silent TBEV infections (> 250/100,000/year), which exceeds the incidence of notified cases (4.7/100,000/year) considerably. (Source: Eurosurveillance)
Source: Eurosurveillance - March 23, 2023 Category: Infectious Diseases Authors: Kathrin Euringer, Philipp Girl, Klaus Kaier, Jan Peilst öcker, Michael Schmidt, Michael Müller-Steinhardt, Beate Rauscher, Evelyn Bressau, Winfried V Kern, Gerhard Dobler and Johannes P Borde Source Type: research
Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021
An individualised blood donor selection policy was implemented in the United Kingdom from summer 2021. We have investigated the impact of this policy by comparing the extent of undeclared use of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) before and after this change. The rate of PrEP usage in syphilis-positive male blood donors has not changed since individualised donor assessment was implemented but provides continuing evidence of undisclosed PrEP use which may be associated with current or past higher-risk sexual behaviours. (Source: Eurosurveillance)
Source: Eurosurveillance - March 16, 2023 Category: Infectious Diseases Authors: Victoria Maddox, Claire Reynolds, Alieu Amara, Laura Else, Susan R Brailsford, Saye Khoo and Heli Harvala Source Type: research
Using an influenza surveillance system to estimate the number of SARS-CoV-2 infections in Beijing, China, weeks 2 to 6 2023
With COVID-19 public health control measures downgraded in China in January 2023, reported COVID-19 case numbers may underestimate the true numbers after the SARS-CoV-2 Omicron wave. Using a multiplier model based on our influenza surveillance system, we estimated that the overall incidence of SARS-CoV-2 infections was 392/100,000 population in Beijing during the 5 weeks following policy adjustment. No notable change occurred after the Spring Festival in early February. The multiplier model provides an opportunity for assessing the actual COVID-19 situation. (Source: Eurosurveillance)
Source: Eurosurveillance - March 16, 2023 Category: Infectious Diseases Authors: Li Zhang, Yi Zhang, Wei Duan, Shuangsheng Wu, Ying Sun, Chunna Ma, Quanyi Wang, Daitao Zhang and Peng Yang Source Type: research
Tap water as the source of a Legionnaires ’ disease outbreak spread to several residential buildings and one hospital, Finland, 2020 to 2021
In Finland, all microbiology laboratories notifyLegionella findings and physicians notify Legionnaires’ disease (LD) cases to the National Infectious Disease Register. All cases are interviewed, and water samples obtained from potential places of exposure.Legionella isolates from humans and water are compared by whole genome sequencing (WGS). In March 2021,Legionella pneumophila serogroup 1 (Lp 1) pneumonia cases increased in one Finnish city (120,000 inhabitants) where single LD cases are detected annually. We identified 12 LD cases, nine living in different residential buildings and three nosocomial, linked by iden...
Source: Eurosurveillance - March 16, 2023 Category: Infectious Diseases Authors: Silja Mentula, Sohvi K ääriäinen, Sari Jaakola, Marjo Niittynen, Piia Airaksinen, Irma Koivula, Markku Lehtola, Ella Mauranen, Isto Mononen, Raija Savolainen, Susanna Haatainen and Outi Lyytikäinen Source Type: research
Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020
ConclusionA close monitoring of ongoing changes to the TBE epidemiological situation in Europe can support the timely adaption of vaccination recommendations. Further analyses to identify populations and geographical areas where vaccination programmes can be of benefit are needed. (Source: Eurosurveillance)
Source: Eurosurveillance - March 16, 2023 Category: Infectious Diseases Authors: Jasper Van Heuverswyn, Luisa K. Hallmaier-Wacker, Julien Beaut é, Joana Gomes Dias, Joana M Haussig, Kristina Busch, Jana Kerlik, Mateusz Markowicz, Henna Mäkelä, Teresa Marie Nygren, Hana Orlíková, Maja Socan, Jakub Zbrzeźniak, Milda Žygutiene an Source Type: research
Environmental surveillance of antimicrobial resistance (AMR), perspectives from a national environmental regulator in 2023
The development, and in some cases increasing prevalence, of resistance to antimicrobials used in clinical and veterinary settings has long been recognised. In recent years, the concept of‘One Health’ has added recognition of the role that the environment plays in health protection along with the need for protection of the health of the environment itself. Organisations including the World Health Organization, United Nations Environment Programme, and national governments have identified a need for surveillance of antimicrobial resistance in the environment to sit alongside the surveillance carried out in clini...
Source: Eurosurveillance - March 16, 2023 Category: Infectious Diseases Authors: Alwyn Hart, Jonathan Warren, Helen Wilkinson and Wiebke Schmidt Source Type: research
Legionnaires ’ disease in the EU/EEA*: increasing trend from 2017 to 2019
ConclusionOur study showed a significant increasing trend in LD cases in the EU/EEA during 2017–19 compared with the previous 5 years. The distribution of cases per week suggests an overall amplification of the seasonal trends. These findings underscore that LD continues to be an infectious disease of public health concern in the EU/EEA, warranting further research into determinants of the increase. (Source: Eurosurveillance)
Source: Eurosurveillance - March 16, 2023 Category: Infectious Diseases Authors: Jonas Samuelsson, Lara Payne Hallstr öm, Gaetano Marrone and Joana Gomes Dias Source Type: research
Authors ’ correction for Euro Surveill. 2023;28(8)
(Source: Eurosurveillance)
Source: Eurosurveillance - March 9, 2023 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research
Author ’s correction for Euro Surveill. 2023;28(9)
(Source: Eurosurveillance)
Source: Eurosurveillance - March 9, 2023 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research
